Ireland· IE-PA-PA0690/005/001
MIBG (123I) 74 MBq/mL solution for injection
A iobenguane (123i) product containing iobenguane, registered in Ireland by Curium Netherlands B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Iobenguane (123i) is registered in 9 of 19 countries.
Countries holding a registration under ATC V09IX01 (iobenguane (123i)), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Iobenguane (123i) · ATC V09IX01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Iobenguane
- Manufacturer
- Curium Netherlands B.V.
- Country
- Ireland (IE)
- ATC code
- V09IX01
- ATC class
- Iobenguane (123I)
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0690/005/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
241 interactions on record for iobenguane (123i).
Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iobenguane (123i) · interactions on record
241 records
- 143 severe
- 98 moderate
Most severe, free to view
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- MazindolA08AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iobenguane (123i) in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c83a89ba-87ee-4a57-b06e-95a877107564 GET /v1/drugs/c83a89ba-87ee-4a57-b06e-95a877107564?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V09IX",
"V09IX01"
],
"strength": null,
"pa_number": "PA0690/005/001",
"substances": [
"Iobenguane"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "18/02/2000",
"dispensing_status": "Product subject to Restricted Prescription (C)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about iobenguane (123i).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.